← Back to Search

Biological

VIA Disc NP for Lower Back Pain

N/A
Waitlist Available
Led By J Kenneth Burkus, MD
Research Sponsored by Vivex Biomedical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1, 3, 6, 12, 24, & 36 months
Awards & highlights

Summary

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

Eligible Conditions
  • Lower Back Pain
  • Back Pain
  • Discogenic Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1, 3, 6, 12, 24, & 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 3, 6, 12, 24, & 36 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient self-reported back pain
Patient self-reporting of daily function
Secondary study objectives
Patient self-reported mental health
Resource Utilization

Trial Design

1Treatment groups
Experimental Treatment
Group I: VIA Disc NPExperimental Treatment1 Intervention
Patients meeting study criteria receiving Vivex VIA Disc NP injection as treatment

Find a Location

Who is running the clinical trial?

Vivex Biomedical, Inc.Lead Sponsor
5 Previous Clinical Trials
306 Total Patients Enrolled
TalosixUNKNOWN
2 Previous Clinical Trials
561 Total Patients Enrolled
VIVEX Biologics, Inc.Lead Sponsor
7 Previous Clinical Trials
806 Total Patients Enrolled
~16 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top